Product Description
Description: Torque’s Torcort H 100 Injection contains Hydrocortisone Sodium Succinate which is an anti-inflammatory adrenocortical steroid. It works on the immune system to help relieve swelling, redness, itching, and allergic reactions.
Pharmaceutical Dosage Form: Dry Injection
Route of Administration: Intramuscular/Intravenous
Composition:
| Each vial contains: | ||
| Hydrocortisone Sodium Succinate eq. to Hydrocortisone | USP | 100 mg |
Mechanism of Action: Hydrocortisone has anti-inflammatory activity resulting from binding with a steroid receptor. It has a membrane sealing effect and inhibits accumulation of neutrophils and macrophages in the region of inflammation. It also reduces the migration of leukocytes and mastocytes into the tissue thus shows anti-proliferative, anti-oedematous effect.
Indications: Torque’s Torcort H100 Injection is indicated for severe allergic, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, nervous system, ophthalmic, renal, respiratory, rheumatic disorders unresponsive to conventional treatments, localized inflammatory or hypertrophic lesions (e.g., alopecia areata, keloids, psoriatic plaques, ganglia). acute and chronic joint or soft tissue inflammatory conditions (e.g., arthritis, bursitis, tenosynovitis).
Dosage: As directed by the physician.
Storage: Store protected from moisture, at a temperature not exceeding 30°C.
Presentation: 100 mg vial
Side effects:
Abdominal distention
Muscle weakness
Loss of muscle mass
Osteoporosis
Hypertension
Fluid & Electrolyte Disturbance
Contraindications: Torque’s Torcort H100 Injection is contraindicated in patients with a known allergy to constituents or excipients, and in idiopathic thrombocytopenic purpura.
Drug Interactions: Torque’s Torcort H100 Injection can cause drug interaction with following drugs:
Anticoagulants
Digoxin
Cyclosporine
Phenobarbital
Phenytoin
Rifampin
Aspirin
Ketoconazole
CYP3A4 Inhibitors
CYP3A4 Inducers
Carbamazepine
Neuromuscular Blocking Agents
Antidiabetics
NSAID’s
